NCM Bioscience Partners, LLC
NCM Bioscience Partners, LLC is a private investment fund based in Leawood, Kansas. Its most recent Form D, filed Feb 17, 2011, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. Related persons named in the filing include x NCM Bioscience Management, LLC; Jeremy Tasset; Daniel Tasset.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Other exemption
- Key people and entities
- x NCM Bioscience Management, LLC; Jeremy Tasset; Daniel Tasset
- Latest Form D
- Feb 17, 2011
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NCM Bioscience Partners, LLC
What is the minimum investment for NCM Bioscience Partners, LLC?
NCM Bioscience Partners, LLC's latest Form D, filed Feb 17, 2011, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in NCM Bioscience Partners, LLC?
NCM Bioscience Partners, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1).
How much has NCM Bioscience Partners, LLC raised?
NCM Bioscience Partners, LLC's latest Form D, filed Feb 17, 2011, reports no sales yet.
Where is NCM Bioscience Partners, LLC based?
NCM Bioscience Partners, LLC is based in Leawood, Kansas.
Size compared with every private investment fund
This fund hasn't reported any sales yet.